SB-224289
SB-224289 is a chemical compound that acts as a selective antagonist for the 5-HT1B receptor, a subtype of the serotonin receptor family. This compound has been utilized in scientific research to explore the role of 5-HT1B receptors in various physiological and pathological processes.
Chemical Structure and Properties[edit]
SB-224289 is characterized by its specific binding affinity to the 5-HT1B receptor, which distinguishes it from other serotonin receptor subtypes. The molecular formula of SB-224289 is C19H20N4O, and it has a molecular weight of 320.39 g/mol. The compound is typically synthesized in laboratory settings for research purposes.
Mechanism of Action[edit]
As a selective antagonist, SB-224289 binds to the 5-HT1B receptor and inhibits its activity. The 5-HT1B receptor is a G protein-coupled receptor (GPCR) that is involved in the modulation of neurotransmitter release, particularly serotonin. By blocking this receptor, SB-224289 can alter serotonin signaling pathways, which has implications for understanding mood regulation, anxiety, and other neuropsychiatric conditions.
Research Applications[edit]
SB-224289 has been used extensively in preclinical studies to investigate the role of 5-HT1B receptors in the central nervous system. Some key areas of research include:
- Mood Disorders: Studies have explored how SB-224289 affects behaviors related to depression and anxiety, providing insights into potential therapeutic targets for these conditions.
- Migraine: The 5-HT1B receptor is implicated in the pathophysiology of migraines, and SB-224289 has been used to study its role in migraine models.
- Substance Use Disorders: Research has examined how SB-224289 influences the rewarding effects of drugs of abuse, contributing to the understanding of addiction mechanisms.
Pharmacokinetics[edit]
The pharmacokinetic profile of SB-224289 includes its absorption, distribution, metabolism, and excretion characteristics. These properties are crucial for determining the compound's efficacy and safety in experimental settings. However, detailed pharmacokinetic data specific to SB-224289 may vary depending on the study design and model organism used.
Safety and Toxicology[edit]
As with many research chemicals, the safety and toxicological profile of SB-224289 is primarily assessed in controlled laboratory environments. Researchers must adhere to safety guidelines and regulations when handling and administering this compound.
Also see[edit]
- 5-HT1B receptor
- Serotonin receptor
- Antagonist (pharmacology)
- Neurotransmitter
- G protein-coupled receptor
-
SB-224289
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
